- Home
- ZLAB vs LEU Comparison
ZLAB vs LEU Comparison
Compare ZLAB & LEU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZLAB
- LEU
- Stock Information
- Founded
- ZLAB 2013
- LEU 1998
- Country
- ZLAB China
- LEU United States
- Employees
- ZLAB N/A
- LEU N/A
- Industry
- ZLAB Biotechnology: Pharmaceutical Preparations
- LEU Mining & Quarrying of Nonmetallic Minerals (No Fuels)
- Sector
- ZLAB Health Care
- LEU Industrials
- Exchange
- ZLAB Nasdaq
- LEU Nasdaq
- Market Cap
- ZLAB 4.0B
- LEU 4.2B
- IPO Year
- ZLAB 2017
- LEU 1998
- Fundamental
- Price
- ZLAB $33.34
- LEU $204.78
- Analyst Decision
- ZLAB Buy
- LEU Buy
- Analyst Count
- ZLAB 6
- LEU 11
- Target Price
- ZLAB $57.22
- LEU $194.80
- AVG Volume (30 Days)
- ZLAB 537.8K
- LEU 1.7M
- Earning Date
- ZLAB 08-07-2025
- LEU 10-27-2025
- Dividend Yield
- ZLAB N/A
- LEU N/A
- EPS Growth
- ZLAB N/A
- LEU 10.12
- EPS
- ZLAB N/A
- LEU 6.16
- Revenue
- ZLAB $427,799,000.00
- LEU $436,900,000.00
- Revenue This Year
- ZLAB $42.62
- LEU $3.52
- Revenue Next Year
- ZLAB $55.12
- LEU $8.01
- P/E Ratio
- ZLAB N/A
- LEU $33.00
- Revenue Growth
- ZLAB 32.56
- LEU 12.72
- 52 Week Low
- ZLAB $18.91
- LEU $34.91
- 52 Week High
- ZLAB $44.34
- LEU $264.90
- Technical
- Relative Strength Index (RSI)
- ZLAB 43.89
- LEU 52.38
- Support Level
- ZLAB $31.79
- LEU $162.10
- Resistance Level
- ZLAB $35.45
- LEU $215.29
- Average True Range (ATR)
- ZLAB 1.00
- LEU 13.53
- MACD
- ZLAB -0.22
- LEU 1.53
- Stochastic Oscillator
- ZLAB 31.12
- LEU 80.24
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.
About LEU Centrus Energy Corp.
Centrus Energy Corp is engaged in the supply of nuclear fuel and services for the nuclear power industry. It operates through the Low-Enriched Uranium (LEU) and Technical Solutions segments. The LEU segment has two components which include the sale of separative work units and uranium. The Technical Solutions segment provides engineering, design, and manufacturing services to government and private sector customers. The majority of the firm's revenue is derived from the LEU segment. It has a business presence in the U.S. and other countries, of which prime revenue is generated in the U.S.